Health     Industry Portals     News     For Consumers     21CFR     Search     Site Map


Content specific to this active ingredient…

Drug Information
Prescribing and patient information from leading authorities

Drug Master Files
Type 2 master files on file at the FDA

Safety Information
For prescription drugs containing this active ingredient

Patent and market exclusivity data

Federal Register
FR search results for this API

FDA Approved Labelling
Information found in this drug's package inserts

Research Links
Chemical identification and research citations

Title 21 Code of Federal Regulations
FDA regulations for this API




FDA Approval Activities for this Drug…

Ganciclovir Sodium Injection, Bedford ANDA 76-222 GANCICLOVIR Capsule; 250MG GANCICLOVIR Ranbaxy | 076457 GANCICLOVIR Capsule; 500MG GANCICLOVIR Ranbaxy | 020460 GANCICLOVIR Capsule; 250MG CYTOVENE ROCHE PALO | 020460 GANCICLOVIR Capsule; 500MG CYTOVENE ROCHE PALO | 020569 GANCICLOVIR Implant; Implantation 4.5MG VITRASERT BAUSCH AND LOMB | 076222 GANCICLOVIR SODIUM Injection 500MG BASE/VIAL GANCICLOVIR SODIUM Bedford | 019661 GANCICLOVIR SODIUM Injection 500MG BASE/VIAL CYTOVENE IV ROCHE PALO | Cytovene (Ganciclovir) Injection, Hoffmann-La Roche, Labeling Revision | Zirgan (ganciclovir) Ophthalmic Gel, Sirion Therapeutics, Inc., Approval | Ganciclovir Injection, APP Pharmaceuticals, LLC, Approval | Cytovene, ganciclovir sodium, Injectable; Injection, Roche Palo, Manufacturing Change or Addition

^ FDA's latest approval appears at the bottom of this list. ^



A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z

Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | Best Phone

© 2016